l carnitine and ssri Acetyl-L-Carnitine as an Add-On Treatment in Fibromyalgia Syndrome: A Retrospective Analysis on 183 Patients, According to the Generalized Linear Mixed Model for Longitudinal Data Current Evidence of Acetyl-L-Carnitine use

Dek modulates global intron retention during muscle stem cells quiescence exit

CagriSema treatment resulted in substantially greater and clinically meaningful weight loss (-20.4%) than semaglutide alone (-14.9%), cagrilintide alone (-11.5%), or placebo (-3.0%), a finding consistent with at least partial additivity, although the study design does not permit a formal assessment of additive or synergistic effects

doi: 10.3389/fmed.2025.1643415 Received 08 June 2025 Accepted 25 September 2025 Published 14 October 2025 Volume 12 - 2025 Edited by Xin Hu, National Center for Child Health and Development (NCCHD), Japan Reviewed by Hua Miao, Northwest University, China Allan Kardec Barros, Universidade Federal do Maranho, Brazil ChandraShekar Annamalai, MVM College of Allied Health Sciences, India Updates Copyright 2025 Wang, Yuan, Wu and Ou

IL-1 and TNF- stimulate chondrocytes and synovial cells to secrete MMP-1, MMP-3, and MMP-13, which degrade collagen and proteoglycans in the cartilage matrix, worsening cartilage damage (150, 151)

1g, 3b, 3e, Supplementary Fig